Most Read Articles
Roshini Claire Anthony, 2 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 5 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Jairia Dela Cruz, 6 days ago
Male smokers under the age of 50 years are at risk of developing ischaemic stroke, and this risk increases with the number of cigarettes smoked daily, according to data from the Stroke Prevention in Young Men Study.
Yesterday
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Atherogenic index of plasma predicts coronary artery disease

06 Oct 2017

The atherogenic index of plasma (AIP) may be a strong and independent predictor of coronary artery disease (CAD) in a Chinese Han population, a new observational study shows.

In the study population of 5,387 individuals (mean age 62.16±9.28 years; 60.18 percent male), 54.5 percent (n=2,935) were CAD patients while 45.5 percent (n=2,452) were healthy controls. Multivariate logistic regression was used to determine the relationship between the risk of CAD and the lipid parameters.

According to Pearson correlation analysis, AIP showed positive and significant correlations with total cholesterol (r=0.125; p<0.001), triglycerides (r=0.810; p<0001), low-density lipoprotein (LDL) cholesterol (r=0.035; p<0.001) and non-high-density lipoprotein (HDL) cholesterol (r=0.322; p<0.001).

The ratio of total cholesterol to HDL cholesterol (r=0.669; p<0.001) and of LDL to HDL cholesterol (r=0.447; p<0.001) likewise showed a significant positive association with AIP.

Both the atherosclerotic index (r=0.669; p<0.001) and lipoprotein combined index (r=0.668; p<0.001) were also positively associated with AIP. In contrast, age (r=-0.122; p<0.001) and HDL cholesterol (r=-0.632; p<0.001) were significantly but negatively correlated with AIP.

Univariate logistic regression showed that AIP correlated strongly with CAD (unadjusted odds ratio [OR], 1.782; 95 percent CI, 1.490 to 2.131; p<0.001). This was followed by the ratio of LDL to HDL cholesterol (unadjusted OR, 1.460; 1.372 to 1.554; p<0.001).

After adjusting for age, sex, smoking, hypertension and diabetes mellitus in multivariate logistic regression, AIP remained the strongest predictor of CAD out of all the lipid parameters (adjusted OR, 1.660; 1.467 to 2.016; p<0.001).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 2 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 5 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Jairia Dela Cruz, 6 days ago
Male smokers under the age of 50 years are at risk of developing ischaemic stroke, and this risk increases with the number of cigarettes smoked daily, according to data from the Stroke Prevention in Young Men Study.
Yesterday
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.